S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
Are These 3 Video Game Stocks Now In Play?
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Agilent Technologies Proves Its Worth VS Illumina 
Target’s Results Cap Upside Potential For Retail Stocks 
Wind energy boom and golden eagles collide in the US West
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Lowe’s Stands Out Amid Q2 Retail Reports 
Egypt's central bank governor resigns as economic woes mount
Stocks slip on Wall Street, erasing weekly gains for S&P 500
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
Are These 3 Video Game Stocks Now In Play?
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Agilent Technologies Proves Its Worth VS Illumina 
Target’s Results Cap Upside Potential For Retail Stocks 
Wind energy boom and golden eagles collide in the US West
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Lowe’s Stands Out Amid Q2 Retail Reports 
Egypt's central bank governor resigns as economic woes mount
Stocks slip on Wall Street, erasing weekly gains for S&P 500
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
Are These 3 Video Game Stocks Now In Play?
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Agilent Technologies Proves Its Worth VS Illumina 
Target’s Results Cap Upside Potential For Retail Stocks 
Wind energy boom and golden eagles collide in the US West
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Lowe’s Stands Out Amid Q2 Retail Reports 
Egypt's central bank governor resigns as economic woes mount
Stocks slip on Wall Street, erasing weekly gains for S&P 500
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
Are These 3 Video Game Stocks Now In Play?
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Agilent Technologies Proves Its Worth VS Illumina 
Target’s Results Cap Upside Potential For Retail Stocks 
Wind energy boom and golden eagles collide in the US West
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Lowe’s Stands Out Amid Q2 Retail Reports 
Egypt's central bank governor resigns as economic woes mount
Stocks slip on Wall Street, erasing weekly gains for S&P 500
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
NASDAQ:HSIC

Henry Schein - HSIC Stock Forecast, Price & News

$74.89
-1.56 (-2.04%)
(As of 08/17/2022 12:00 AM ET)
Add
Compare
Today's Range
$74.83
$76.31
50-Day Range
$73.17
$82.24
52-Week Range
$70.25
$92.68
Volume
560,078 shs
Average Volume
915,195 shs
Market Capitalization
$10.19 billion
P/E Ratio
16.07
Dividend Yield
N/A
Price Target
$85.89

Henry Schein MarketRank™ Forecast

Analyst Rating
Hold
2.25 Rating Score
Upside/​Downside
14.7% Upside
$85.89 Price Target
Short Interest
Healthy
2.87% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.99
Upright™ Environmental Score
News Sentiment
0.38mentions of Henry Schein in the last 14 days
Based on 12 Articles This Week
Insider Trading
Selling Shares
$981,965 Sold Last Quarter
Proj. Earnings Growth
6.60%
From $4.85 to $5.17 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.45 out of 5 stars

Medical Sector

231st out of 1,122 stocks

Medical & Hospital Equipment Industry

2nd out of 3 stocks

HSIC stock logo

About Henry Schein (NASDAQ:HSIC) Stock

Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Henry Schein Trading Down 2.0 %

NASDAQ:HSIC traded down $1.56 during trading on Wednesday, reaching $74.89. 560,078 shares of the stock traded hands, compared to its average volume of 915,195. The firm has a market cap of $10.19 billion, a price-to-earnings ratio of 16.07, a price-to-earnings-growth ratio of 2.09 and a beta of 0.75. The stock's 50-day moving average price is $76.64 and its 200 day moving average price is $82.08. The company has a quick ratio of 0.95, a current ratio of 1.83 and a debt-to-equity ratio of 0.18. Henry Schein has a fifty-two week low of $70.25 and a fifty-two week high of $92.68.

Henry Schein (NASDAQ:HSIC - Get Rating) last issued its quarterly earnings data on Tuesday, August 2nd. The company reported $1.16 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $1.16. The firm had revenue of $3.03 billion during the quarter, compared to analysts' expectations of $3.12 billion. Henry Schein had a net margin of 5.11% and a return on equity of 15.56%. The business's revenue for the quarter was up 2.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.11 earnings per share. Analysts predict that Henry Schein will post 4.85 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have weighed in on the stock. Evercore ISI dropped their target price on shares of Henry Schein to $83.00 in a research note on Tuesday, August 9th. Stifel Nicolaus dropped their target price on shares of Henry Schein from $90.00 to $80.00 in a research note on Friday, June 17th. StockNews.com downgraded shares of Henry Schein from a "strong-buy" rating to a "buy" rating in a research note on Tuesday, July 19th. UBS Group raised shares of Henry Schein from a "sell" rating to a "neutral" rating and set a $80.00 target price for the company in a research note on Monday, August 8th. Finally, Credit Suisse Group dropped their target price on shares of Henry Schein from $100.00 to $90.00 and set an "outperform" rating for the company in a research note on Wednesday, August 3rd. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $85.89.

Insider Activity at Henry Schein

In other news, EVP Gerald A. Benjamin sold 11,489 shares of the company's stock in a transaction that occurred on Thursday, May 26th. The shares were sold at an average price of $85.47, for a total value of $981,964.83. Following the completion of the transaction, the executive vice president now owns 95,616 shares in the company, valued at $8,172,299.52. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 1.00% of the company's stock.

Receive HSIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Henry Schein and its competitors with MarketBeat's FREE daily newsletter.

HSIC Stock News Headlines

UBS Group Upgrades Henry Schein (NASDAQ:HSIC) to Neutral
Expert Ratings for Henry Schein
Henry Schein (HSIC) Q2 2022 Earnings Call Transcript
See More Headlines
Receive HSIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Henry Schein and its competitors with MarketBeat's FREE daily newsletter.

HSIC Company Calendar

Last Earnings
8/02/2022
Today
8/17/2022
Next Earnings (Estimated)
11/01/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Medical & hospital equipment
Sub-Industry
Health Care Distributors
Sector
Medical
Current Symbol
NASDAQ:HSIC
CUSIP
80640710
Employees
21,600
Year Founded
1932

Price Target and Rating

Average Stock Price Forecast
$85.89
High Stock Price Forecast
$99.00
Low Stock Price Forecast
$72.00
Forecasted Upside/Downside
+14.7%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
8 Analysts

Profitability

Net Income
$631.23 million
Pretax Margin
6.70%

Debt

Sales & Book Value

Annual Sales
$12.40 billion
Cash Flow
$5.92 per share
Book Value
$31.06 per share

Miscellaneous

Free Float
134,754,000
Market Cap
$10.19 billion
Optionable
Optionable
Beta
0.75

Social Links















HSIC Stock - Frequently Asked Questions

Should I buy or sell Henry Schein stock right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Henry Schein in the last twelve months. There are currently 1 sell rating, 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" HSIC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HSIC, but not buy additional shares or sell existing shares.
View HSIC analyst ratings
or view top-rated stocks.

What is Henry Schein's stock price forecast for 2022?

8 Wall Street analysts have issued twelve-month target prices for Henry Schein's stock. Their HSIC share price forecasts range from $72.00 to $99.00. On average, they expect the company's stock price to reach $85.89 in the next year. This suggests a possible upside of 14.7% from the stock's current price.
View analysts price targets for HSIC
or view top-rated stocks among Wall Street analysts.

How have HSIC shares performed in 2022?

Henry Schein's stock was trading at $77.53 at the start of the year. Since then, HSIC stock has decreased by 3.4% and is now trading at $74.89.
View the best growth stocks for 2022 here
.

When is Henry Schein's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 1st 2022.
View our HSIC earnings forecast
.

How were Henry Schein's earnings last quarter?

Henry Schein, Inc. (NASDAQ:HSIC) announced its quarterly earnings results on Tuesday, August, 2nd. The company reported $1.16 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $1.16. The business had revenue of $3.03 billion for the quarter, compared to the consensus estimate of $3.12 billion. Henry Schein had a net margin of 5.11% and a trailing twelve-month return on equity of 15.56%. Henry Schein's revenue for the quarter was up 2.1% on a year-over-year basis. During the same period in the previous year, the company earned $1.11 EPS.
Read the conference call transcript
.

When did Henry Schein's stock split?

Shares of Henry Schein split on the morning of Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly minted shares were payable to shareholders after the market closes on Thursday, September 14th 2017. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

How will Henry Schein's stock buyback program work?

Henry Schein announced that its board has initiated a stock buyback program on Thursday, May 13th 2021, which permits the company to repurchase $400,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to buy up to 3.6% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company's board of directors believes its stock is undervalued.

What guidance has Henry Schein issued on next quarter's earnings?

Henry Schein updated its FY 2022 earnings guidance on Tuesday, August, 9th. The company provided EPS guidance of $4.75-$4.91 for the period, compared to the consensus EPS estimate of $4.86. The company issued revenue guidance of $12.77 billion-$13.14 billion, compared to the consensus revenue estimate of $13.05 billion.

What is Stanley M. Bergman's approval rating as Henry Schein's CEO?

451 employees have rated Henry Schein Chief Executive Officer Stanley M. Bergman on Glassdoor.com. Stanley M. Bergman has an approval rating of 94% among the company's employees. This puts Stanley M. Bergman in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Henry Schein own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Henry Schein investors own include Alibaba Group (BABA), Pfizer (PFE), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), NVIDIA (NVDA), QUALCOMM (QCOM), CVS Health (CVS), Micron Technology (MU) and AT&T (T).

What is Henry Schein's stock symbol?

Henry Schein trades on the NASDAQ under the ticker symbol "HSIC."

Who are Henry Schein's major shareholders?

Henry Schein's stock is owned by a variety of institutional and retail investors. Top institutional investors include State Street Corp (5.13%), Pendal Group Ltd (2.54%), JPMorgan Chase & Co. (2.43%), Macquarie Group Ltd. (1.66%), FMR LLC (1.60%) and Massachusetts Financial Services Co. MA (1.52%). Insiders that own company stock include Deborah Derby, Gerald A Benjamin, James P Breslawski, James P Breslawski, Kurt P Kuehn, Mark E Mlotek, Michael S Ettinger, Paul Brons, Scott Philip Serota, Stanley M Bergman, Steven Paladino and Walter Siegel.
View institutional ownership trends
.

How do I buy shares of Henry Schein?

Shares of HSIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Henry Schein's stock price today?

One share of HSIC stock can currently be purchased for approximately $74.89.

How much money does Henry Schein make?

Henry Schein (NASDAQ:HSIC) has a market capitalization of $10.19 billion and generates $12.40 billion in revenue each year. The company earns $631.23 million in net income (profit) each year or $4.66 on an earnings per share basis.

How many employees does Henry Schein have?

The company employs 21,600 workers across the globe.

Does Henry Schein have any subsidiaries?
The following companies are subsidiares of Henry Schein: ACE Surgical Supply Co., ADS Florida, AUV Veterinary Services, Accord, Alpha Scientific, Arcade Dentaire, Arseus, Arseus Dental Solutions, Arseus Lab, Becker-Parkin Dental Supply, BioHorizons Inc., Butler Schein Animal Health, C&M Vetlink, Camlog USA Inc., DNA Anthos Impianti, Dental Cremer, Dental Trey, Elite Computer Italia, Exan Enterprises Inc., General Injectables & Vaccines Inc., HS Brand Management Inc., HS TM Holdings LLC, Handpiece Parts & Repairs Inc., Henry Schein Europe Inc., Henry Schein Latin America Pacific Rim Inc., Henry Schein Medical Systems Inc., Henry Schein Practice Solutions Inc., Jorgen Kruuse, Lincoln Dental Supply, Logiciel Julie, Maddox Practice Group, Maravet, Marrodent, Medivet, Medka, Minerva Dental Limited, Modern Laboratory Services, NLS Animal Health, Noviko, Ortho Organizers, Ortho Technology, Project Helium Holdings LLC, Project Spartan Holdings Corp., RxWorks, SG Healthcare Corp, Sirona Direct, SmartPak Equine LLC, Software of Excellence, Sogim Grimouille, Southern Anesthesia & Surgical, The Exan Group, Veterinary Instrumentation, Vetstreet, W. & J. Dunlop, and scil animal care.
Read More
When was Henry Schein founded?

Henry Schein was founded in 1932.

How can I contact Henry Schein?

Henry Schein's mailing address is 135 DURYEA RD, MELVILLE NY, 11747. The official website for the company is www.henryschein.com. The company can be reached via phone at (631) 843-5500, via email at steven.paladino@henryschein.com, or via fax at 631-843-5541.

This page (NASDAQ:HSIC) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.